Evaluation of antimicrobial activity of ellagic acid on Methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, and Escherichia coli

Zainab G. Aljassim; Haitham M. Kadhim; Abbas S. Al-Mizraqchi

doi:10.53730/ijhs.v6nS3.8956

Authors

Zainab G. Aljassim Parmacology Department/ College of Dentistry/ Baghdad University/Iraq
Haitham M. Kadhim Parmacology Department / College of Medicine/Al-Nahrain University/Iraq
Abbas S. Al-Mizraqchi Medical Microbiology Department/ College of Dentistry/ Baghdad University/Iraq

Keywords:

pathogenic bacteria, ellagic acid, antibacterial activity

Abstract

Serious infections, and rising resistant infections, by pathogenic bacteria, have become developing threats worldwide. There is an increasing need to develop and discover a new treatment options that can act effectively to cure infections, with lesser resistance, side effects and toxicity. Identification of new treatment options against pathogens is an important issue nowadays. Ellagic acid is a non-drug compound that has been shown to possess many biological activities and is presented in many red fruits and berries. This study aims to evaluate and measure the antimicrobial activity and the minimum bactericidal concentration (MBC) of ellagic acid on Methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, and Escherichia coli. The antibacterial activity of ellagic acid was evaluated against ten purified bacterial isolates via agar disc diffusion assay, and minimum bactericidal concentration assay (MBC). The results show that ellagic acid was an effective antimicrobial compound against all the tested pathogens. The MBC range was shown to be between (1-2) mg/ml for MRSA, and E.coli, and between(1-1.5) mg/ml for P. aeruginosa. This current study has detected and proved the antimicrobial activity of ellagic acid against important and widely resistant pathogenic bacteria like MRSA, P. aeruginosa, and E.coli.

Downloads

Download data is not yet available.

References

Abd-Awn, B. H., AL-Dhaher, Z. A. and Al-Dafaai, R. R. (2012). The effect of black seed oil extracts on mutans streptococci in comparison to chlorhexidine gluconate (in vitro). J Bagh College Dentistry, 24(4), 126-131.

Ahad A, Ganai AA, Mujeeb M, Siddiqui WA. (2014).Ellagic acid, an NF-κB inhibitor, ameliorates renal function in experimental diabetic nephropathy. Chem Biol Interact. 5;219:64-75.

Beighton, D. (1985). Isolation and identification of microorganism of medical and veterinary importance. London, Academic press.p.177-190.

Ceci, C., Lacal, P. M., Tentori, L., De Martino, M. G., Miano, R., & Graziani, G. (2018). Experimental evidence of the antitumor, antimetastatic and antiangiogenic activity of ellagic acid. Nutrients, 10(11), 1756.‏

Chambers, S. A., Gaddy, J. A., & Townsend, S. D. (2020). Synthetic Ellagic Acid Glycosides Inhibit Early Stage Adhesion of Streptococcus agalactiae Biofilms as Observed by Scanning Electron Microscopy. Chemistry (Weinheim an der Bergstrasse, Germany), 26(44), 9923–9928.

Cornélio F D, Martins T M, Lemos de A E, de Freitas A C, Lazo C JE, Artério S C, Faccioli LH, Paula R A.(2013). Antiinflammatory effects of ellagic acid on acute lung injury induced by acid in mice. Mediators Inflamm 2013: 1–13

Dan Z , Ze-Hua L, Dong-Mei W , Deng-Wu L, Li-Na Y and Wei W (2019). Chemical composition, antibacterial activity and related mechanism of valonia and shell from Quercus variabilis Blume (Fagaceae) against Salmonella paratyphia and Staphylococcus aureus. BMC Complementary and Alternative Medicine 19:271

Devipriya, N., Sudheer, A. R., Vishwanathan, P., & Menon, V. P. (2008). Modulatory potential of ellagic acid, a natural plant polyphenol on altered lipid profile and lipid peroxidation status during alcohol‐induced toxicity: A pathohistological study. Journal of Biochemical and Molecular Toxicology, 22(2), 101-112.‏

El-Shitany NA, El-Bastawissy EA, El-desoky (2014). Ellagic acid protects against carrageenan-induced acute inflammation through inhibition of nuclear factor kappa B, inducible cyclooxygenase and proinflammatory cytokines and enhancement of interleukin-10 via an antioxidant mechanism. K.Int Immunopharmacol. 19(2):290-9.

Finegold, S. M. and Baron, E. J. (1986). Methods for identification of etiologic agents of infectious disease. In: Baily and Scott's diagnostic microbiology. 7th ed. St. Louis: The CV Mosby Co., 382-422.

Genskowsky, E., Puente, L. A., Pérez‐Álvarez, J. A., Fernández‐López, J., Muñoz, L. A., & Viuda‐Martos, M. (2016). Determination of polyphenolic profile, antioxidant activity and antibacterial properties of maqui [Aristotelia chilensi s (Molina) Stuntz] a Chilean blackberry. Journal of the Science of Food and Agriculture, 96(12), 4235-4242.‏

Ghadimi, M., Foroughi, F., Hashemipour, S., Rashidi Nooshabadi, M., Ahmadi, M. H., Ahadi Nezhad, B., & Khadem Haghighian, H. (2021). Randomized double‐blind clinical trial examining the Ellagic acid effects on glycemic status, insulin resistance, antioxidant, and inflammatory factors in patients with type 2 diabetes. Phytotherapy Research, 35(2), 1023-1032.‏

González-Sarrías A, Larrosa M, Tomás-Barberán F, Dolara P, Espín J. (2010). NFκB-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblasts. Br J Nutr 104: 503–512

Grasser, Georg; Enna, F. G. A. (1922). Synthetic Tannins. p. 20.

Infante, R.; Contador, L.; Rubio, P.; Aros, D.; Peña Neira, Á. (2011). "Postharvest sensory and phenolic characterization of 'Elegant Lady' and 'Carson' peaches" (PDF). Chilean Journal of Agricultural Research. 71 (3): 445–451.

Larrosa, M.; González S A.; García CM. T.; Tomás B F. A.; Espín, J. C. (2006). Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities". Journal of Agricultural and Food Chemistry. 54 (5): 1611–1620.

Lee J, Won J, Choi J, Cha H, Jang Y, Park S, Kim HG, Kim HC, Kim DK. (2014).Protective effect of ellagic acid on concanavalin A induced hepatitis via toll-like receptor and mitogen-activated protein kinase/nuclear factor κB signaling pathways. J Agric Food Chem 62: 10110–10117

Luca SV, Macovei I, Bujor A, Trifan A (2020). Bioactivity of dietary polyphenols: The role of metabolites. Critical Reviews in Food Science and Nutrition. 60 (4): 626–659.

Mishra S, Vinayak M. (2014).Ellagic acid inhibits PKC signaling by improving antioxidant defense system in murine T cell lymphoma. Mol Biol Rep 41: 4187–4197

Priyadarsini, K. I., Khopde, S. M., Kumar, S. S., & Mohan, H. (2002). Free radical studies of ellagic acid, a natural phenolic antioxidant. Journal of agricultural and food chemistry, 50(7), 2200-2206.‏

Reddy BU, Mullick R, Kumar A, Sudha G, Srinivasan N, Das S. (2014).Small molecule inhibitors of HCV replication from pomegranate. Sci Rep 4: 5411

Ríos, J. L., Giner, R. M., Marín, M., & Recio, M. C. (2018). A pharmacological update of ellagic acid. Planta Medica, 84(15), 1068-1093.‏

Salini, R., & Pandian, S. K. (2015). Interference of quorum sensing in urinary pathogen Serratia marcescens by Anethum graveolens. Pathogens and Disease, 73(6), ftv038.‏

Sarabhai, S., Harjai, K., Sharma, P., & Capalash, N. (2015). Ellagic acid derivatives from Terminalia chebula Retz. increase the susceptibility of Pseudomonas aeruginosa to stress by inhibiting polyphosphate kinase. Journal of applied microbiology, 118(4), 817-825.‏

Soh PN, Witkowski B, Olagnier D, Nicolau ML, Garcia-Alvarez MC, Berry A, Benoit-Vical F. (2009).In vitro and in vivo properties of ellagic acid in malaria treatment. Antimicrob Agents Chemother 53: 1100–1106

Truchado, P., Giménez-Bastida, J. A., Larrosa, M., Castro-Ibáñez, I., Espı́n, J. C., Tomás-Barberán, F. A., & Allende, A. (2012). Inhibition of quorum sensing (QS) in Yersinia enterocolitica by an orange extract rich in glycosylated flavanones. Journal of Agricultural and Food Chemistry, 60(36), 8885-8894.‏

Usta, C.; Özdemir, S.; Schiariti, M.; Puddu, P. E. (2013). The pharmacological use of ellagic acid-rich pomegranate fruit". International Journal of Food Sciences and Nutrition. 64 (7): 907–913.

Vlachojannis, C.; Zimmermann, B.F.; Chrubasik-Hausmann, S. (2015). Efficacy and safety of pomegranate medicinal products for cancer. Evid. Based Complement. Altern. Med. 258598. doi: 10.1155/2015/258598. Epub 2015 Mar 1. PMID: 25815026; PMCID: PMC4359844.

Yoshimura, Y., Nishii, S., Zaima, N., Moriyama, T., & Kawamura, Y. (2013). Ellagic acid improves hepatic steatosis and serum lipid composition through reduction of serum resistin levels and transcriptional activation of hepatic ppara in obese, diabetic KK-Ay mice. Biochemical and biophysical research communications, 434(3), 486-491.‏

Rinartha, K., Suryasa, W., & Kartika, L. G. S. (2018). Comparative Analysis of String Similarity on Dynamic Query Suggestions. In 2018 Electrical Power, Electronics, Communications, Controls and Informatics Seminar (EECCIS) (pp. 399-404). IEEE.

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Get vaccinated when it is your turn and follow the local guidelines. International Journal of Health Sciences, 5(3), x-xv. https://doi.org/10.53730/ijhs.v5n3.2938

Khikmatullaeva, Khaydarov, N. K., Abdullaeva, M. B., & Aktamova, M. U. (2021). Cognitive disorders in stroke. International Journal of Health & Medical Sciences, 4(2), 202-207. https://doi.org/10.31295/ijhms.v4n2.1700